Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Laryngeal Diseases × capmatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 3 Neoplasms 2 Sarcoma 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Lymphoproliferative Disorders 1 Hematologic Neoplasms 1 EGFR-mutant Non-small Cell Lung Cancer 1 Carcinoma 1 Bronchial Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

pembrolizumab 3 Cisplatin 3 Surveys and Questionnaires 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2 Cetuximab 2 monalizumab 1 linrodostat 1 durvalumab 1 Tablets 1 Surgical Flaps 1 Radiation 1 Metformin 1 LY2940680 1 Ipilimumab 1 Interviews as Topic 1 Fluorouracil 1 Docetaxel 1 Combined Modality Therapy 1 Chemical Fractionation 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡